Arce von HM

Language: Spanish
References: 20
Page: 643-647
PDF size: 156.50 Kb.

ABSTRACT

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD) syndrome is a potentially lethal pediatric disorder of uncertain etiology that involves multiple systems and should be detected early to assure treatment by various pediatric specialists and reduce possible fatal consequences.

REFERENCES

1. Abaci, A., et al. (2013). “A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: ROHHADNET syndrome.” Endocr Pract 19(1): e12-16.

2. Antic, N. A., et al. (2006). “PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood.” Am J Respir Crit Care Med 174(8): 923- 927.

3. Bougnères, P., et al. (2008). “Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood.” J Clin Endocrinol Metab 93(10): 3971-3980.

4. Chew, H. B., et al. (2011). “Rapidonset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD): a case with additional features and review of the literature.” BMJ Case Rep 2011.

5. De Pontual, L., et al. (2008). “Delineation of late onset hypoventilation associated with hypothalamic dysfunction syndrome.” Pediatr Res 64(6): 689- 694.

6. Del Carmen Sanchez, M., et al. (1996). “Late onset central hypoventilation syndrome.” Pediatr Pulmonol 21(3): 189-191.

7. duRivage, S. K., et al. (1985). “Idiopathic hypothalamic dysfunction and impaired control of breathing.” Pediatrics 75(5): 896- 898.

8. FISHMAN, L. S., et al. (1965). “PRIMARY ALVEOLAR HYPOVENTILATION SYNDROME (ONDINE’S CURSE).” Am J Dis Child 110: 155- 161.

9. Geoerger, B., et al. (2001). “Metabolic activity and clinical features of primary ganglioneuromas.” Cancer 91(10): 1905-1913.

10. Huppke, P., et al. (2009). “Immunoglobulin therapy in idiopathic hypothalamic dysfunction.” Pediatr Neurol 41(3): 232-234.

11. Ize-Ludlow, D., et al. (2007). “Rapidonset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood.” Pediatrics 120(1): e179-188.

12. Katz, E. S., et al. (2000). “Lateonset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome.” Pediatr Pulmonol 29(1): 62-68.

13. North, K. N., et al. (1994). “Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: report of two cases.” J Child Neurol 9(3): 320-325.

14. Nunn, K., et al. (1997). “Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome?” J Child Neurol 12(4): 276-281.

15. Ouvrier, R., et al. (1995). “Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome?” Lancet 346(8985): 1298.

16. Patwari, P. P., et al. (2011). “Monozygotic twins discordant for ROHHAD phenotype.” Pediatrics 128(3): e711-715.

17. Paz-Priel, I., et al. (2011). “Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.” J Pediatr 158(2): 337-339.

18. 18. Rand, C. M., et al. (2011). “Rapidonset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes.” Pediatr Res 70(4): 375-378.

19. Sartori, S., et al. (2013). “Intrathecal Synthesis of Oligoclonal Bands in Rapid-Onset Obesity With Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome: New Evidence Supporting Immunological Pathogenesis.” J Child Neurol.

20. Sirvent, N., et al. (2003). “Hypothalamic dysfunction associated with neuroblastoma: evidence for a new Paraneoplastic syndrome?” Med Pediatr Oncol 40(5): 326-328.